On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...